These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20820843)

  • 1. Peroxisome proliferator-activated receptor gamma in osteoarthritis.
    Fahmi H; Martel-Pelletier J; Pelletier JP; Kapoor M
    Mod Rheumatol; 2011 Feb; 21(1):1-9. PubMed ID: 20820843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype.
    Vasheghani F; Monemdjou R; Fahmi H; Zhang Y; Perez G; Blati M; St-Arnaud R; Pelletier JP; Beier F; Martel-Pelletier J; Kapoor M
    Am J Pathol; 2013 Apr; 182(4):1099-106. PubMed ID: 23375622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
    Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
    Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
    Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
    Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
    Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
    Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
    Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective STAT3 inhibitor STX-0119 alleviates osteoarthritis progression by modulating the STAT3/PPARγ signaling pathway.
    Lu X; Xu Y; Li X; Wang J; Wang L; Hu X; Fan H; Pang F; Li X; Pan X; He W; Li J; Dai Z
    Biochem Pharmacol; 2024 Sep; 227():116420. PubMed ID: 38996934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PPARγ gene polymorphisms with osteoarthritis in a southeast Chinese population.
    Zheru D; Peiliang F; Yuli W; Haishan W; Qirong Q; Xiaohua L; Hui Z; Bo W; Qiwei F
    J Genet; 2014 Dec; 93(3):719-23. PubMed ID: 25572230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands as potential therapeutic agents to treat arthritis.
    Giaginis C; Giagini A; Theocharis S
    Pharmacol Res; 2009 Sep; 60(3):160-9. PubMed ID: 19646655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases - the pro and con of agonists].
    Jouzeau JY; Moulin D; Koufany M; Sebillaud S; Bianchi A; Netter P
    J Soc Biol; 2008; 202(4):289-312. PubMed ID: 19094928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms.
    Jackson MT; Moradi B; Zaki S; Smith MM; McCracken S; Smith SM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Dec; 66(12):3337-48. PubMed ID: 25200274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor γ expression in human osteoarthritic chondrocytes.
    Nebbaki SS; El Mansouri FE; Afif H; Kapoor M; Benderdour M; Duval N; Pelletier JP; Martel-Pelletier J; Fahmi H
    Arthritis Res Ther; 2012 Mar; 14(2):R69. PubMed ID: 22455954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts.
    Malaise O; Relic B; Quesada-Calvo F; Charlier E; Zeddou M; Neuville S; Gillet P; Louis E; de Seny D; Malaise MG
    Rheumatology (Oxford); 2015 Jun; 54(6):1087-92. PubMed ID: 25389358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway.
    Lu J; Guan H; Wu D; Hu Z; Zhang H; Jiang H; Yu J; Zeng K; Li H; Zhang H; Pan C; Cai D; Yu X
    J Cell Mol Med; 2021 Jul; 25(14):6664-6678. PubMed ID: 34117708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of Epigenetic Peroxisome Proliferator-Activated Receptor-γ Suppression by Diacerein Alleviates Oxidative Stress and Osteoarthritis in Mice.
    Chen X; Zhu X; Dong J; Chen F; Gao Q; Zhang L; Cai D; Dong H; Ruan B; Wang Y; Jiang Q; Cao W
    Antioxid Redox Signal; 2022 Jul; 37(1-3):40-53. PubMed ID: 35196878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.